Skip to content

Risk Prediction for Contrast Induced Nephropathy in patients with renal impairment

Risk prediction for Contrast Induced Nephropathy in patients with renal impairment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/06/019604
Enrollment
500
Registered
2019-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: I219- Acute myocardial infarction, unspecified

Interventions

None listed

Sponsors

GE Healthcare Limited
Lead Sponsor
The Madras Medical Mission
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive patients aged 18 to 80 years, who undergo PCI in the study sites can be enrolled into the study, if their GFR is 15- 60ml/min/1.73m2, in whom Iodixanol is the contrastmedia of choice. The screening tests required for the study must be performed in all patients.

Exclusion criteria

Exclusion criteria: Evidence of acute renal failure before PCI, patients on regular dialysis, cardiogenic shock, patients who were exposed to contrast media within 14 days, patients exposed to nephrotoxic medication within 48hours of the procedure, patients requiring intra-aortic balloon pump (IABP) support and patients who developed PCI related complications will be ex¬cluded.

Design outcomes

Primary

MeasureTime frame
No outcome for this studyTimepoint: No outcome for this study

Secondary

MeasureTime frame
No outcome for this studyTimepoint: No outcome for this study

Countries

India

Contacts

Public ContactDr Ajit S Mullasari

The Madras Medical Mission

clireco@mmm.org.in919841271361

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026